{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:31:18Z","timestamp":1787167878936,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.05.031","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T09:45:12Z","timestamp":1217843112000},"page":"80-84","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Inmaculada B.","family":"Aban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil I.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Alfred","family":"Jaretzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Minisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Conwit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newsom-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MGTX","family":"Advisory Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.05.031_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1748-5991.2007.00025.x","article-title":"Regulatory innovation in the governance of human subjects research: a cautionary tale and some modest proposals","volume":"2","author":"Burris","year":"2008","journal-title":"Regul. Govern."},{"key":"10.1016\/j.jneuroim.2008.05.031_bib2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","article-title":"Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians","volume":"37","author":"Chiu","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib3","doi-asserted-by":"crossref","first-page":"306S","DOI":"10.1016\/S0197-2456(03)00100-4","article-title":"The role of the data coordinating center in the IRB review and approval process: the DIG trial experience","volume":"24","author":"Collins","year":"2003","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen, and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1740774507087704","article-title":"Specific barriers to the conduct of randomized trials","volume":"5","author":"Duley","year":"2008","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.nmd.2007.07.002","article-title":"Myasthenia gravis in South Africans: racial differences in clinical manifestations","volume":"17","author":"Heckmann","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2008.05.031_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0197-2456(01)00183-0","article-title":"Regulatory approvals in a large multinational clinical trial: the ESPRIT experience","volume":"23","author":"McNay","year":"2002","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1196\/annals.1405.014","article-title":"Status of the thymectomy trial for non-thymomatous myasthenia gravis patients receiving prednisone","volume":"1132","author":"Newsom-Davis","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.05.031_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.05.031_bib10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.42.10.1888","article-title":"The epidemiology of myasthenia gravis in central and western Virginia","volume":"42","author":"Phillips","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.05.031_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1196\/annals.1254.061","article-title":"Thymectomy trial in non-thymomatous myasthenia gravis patients receiving immunosuppressive therapy","volume":"998","author":"Wolfe","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.05.031_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0404.1992.tb08056.x","article-title":"Myasthenia gravis in Hong Kong Chinese","volume":"86","author":"Wong","year":"1992","journal-title":"Acta Neurol. Scand."}],"updated-by":[{"DOI":"10.1016\/j.jneuroim.2009.07.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T00:00:00Z","timestamp":1260403200000}}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T14:52:55Z","timestamp":1545835975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":12,"alternative-id":["S0165572808002038"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.031","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}